Production (Stage)
X4 Pharmaceuticals, Inc.
XFOR
$3.10
-$0.13-4.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.52% | -10.64% | -4.73% | 19.42% | -13.42% |
| Total Receivables | 67.24% | 204.27% | 173.03% | 4.15% | 6.69% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -22.20% | -20.72% | -19.28% | -5.56% | 47.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 9.58% | -8.11% | -3.31% | 18.81% | -11.09% |
|
|
|||||
| Total Current Assets | 9.58% | -8.11% | -3.31% | 18.81% | -11.09% |
| Net Property, Plant & Equipment | -31.09% | -24.30% | -22.49% | -22.40% | -23.30% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 101.94% | 44.85% | 89.95% | 65.80% | 48.90% |
| Total Assets | 15.89% | -0.55% | 2.81% | 21.46% | -9.83% |
|
|
|||||
| Total Accounts Payable | 24.40% | -3.64% | 5.47% | 56.34% | 49.12% |
| Total Accrued Expenses | -6.40% | 79.50% | 20.24% | 30.19% | 14.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.00% | 13.83% | 9.50% | -38.70% | -34.47% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.95% | 43.81% | 15.04% | 29.89% | 20.83% |
|
|
|||||
| Total Current Liabilities | 9.95% | 43.81% | 15.04% | 29.89% | 20.83% |
| Long-Term Debt | 37.95% | 38.22% | 38.48% | 135.68% | 72.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -52.16% | -46.02% | -38.31% | -35.15% | -31.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -85.40% | -9.49% | -46.72% | -79.03% | 68.84% |
| Total Liabilities | -3.67% | 29.26% | 12.15% | 9.73% | 52.82% |
|
|
|||||
| Common Stock & APIC | 1.37% | 1.61% | 1.67% | 1.78% | 17.30% |
| Retained Earnings | 2.76% | -7.84% | -3.65% | 3.86% | -32.17% |
| Treasury Stock & Other | 17.42% | -2.52% | 4.20% | -33.61% | -30.25% |
| Total Common Equity | 2,114.67% | -56.65% | -11.80% | 39.85% | -98.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2,114.67% | -56.65% | -11.80% | 39.85% | -98.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2,114.67% | -56.65% | -11.80% | 39.85% | -98.00% |
|
|
|||||